Clinical Trial Update: Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan [Phase 3]

View source ↗

Summary

Phase 3 efficacy and safety study MT-6548 in non-dialysis chronic kidney disease patients with anemia has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• MT-6548

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Anemia; Non-dialysis Dependent Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-04-12